BXP INC (BXP) Fundamental Analysis & Valuation

NYSE:BXP • US1011211018

Current stock price

55.63 USD
+0.6 (+1.09%)
Last:

This BXP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BXP Profitability Analysis

1.1 Basic Checks

  • In the past year BXP was profitable.
  • In the past year BXP had a positive cash flow from operations.
  • BXP had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BXP had a positive operating cash flow.
BXP Yearly Net Income VS EBIT VS OCF VS FCFBXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • BXP has a Return On Assets (1.06%) which is comparable to the rest of the industry.
  • With a decent Return On Equity value of 5.38%, BXP is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • BXP's Return On Invested Capital of 3.20% is fine compared to the rest of the industry. BXP outperforms 61.79% of its industry peers.
  • BXP had an Average Return On Invested Capital over the past 3 years of 3.24%. This is in line with the industry average of 3.13%.
Industry RankSector Rank
ROA 1.06%
ROE 5.38%
ROIC 3.2%
ROA(3y)0.61%
ROA(5y)1.51%
ROE(3y)2.96%
ROE(5y)6.24%
ROIC(3y)3.24%
ROIC(5y)3.38%
BXP Yearly ROA, ROE, ROICBXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • BXP has a Profit Margin (7.95%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of BXP has declined.
  • The Operating Margin of BXP (29.13%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BXP has declined.
  • BXP has a Gross Margin of 60.17%. This is in the lower half of the industry: BXP underperforms 66.67% of its industry peers.
  • BXP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.13%
PM (TTM) 7.95%
GM 60.17%
OM growth 3Y-5.16%
OM growth 5Y-2.34%
PM growth 3Y-33.71%
PM growth 5Y-23.91%
GM growth 3Y-1.51%
GM growth 5Y-0.7%
BXP Yearly Profit, Operating, Gross MarginsBXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. BXP Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BXP is destroying value.
  • The number of shares outstanding for BXP has been increased compared to 1 year ago.
  • The number of shares outstanding for BXP has been increased compared to 5 years ago.
  • The debt/assets ratio for BXP is higher compared to a year ago.
BXP Yearly Shares OutstandingBXP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BXP Yearly Total Debt VS Total AssetsBXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • BXP has an Altman-Z score of 0.48. This is a bad value and indicates that BXP is not financially healthy and even has some risk of bankruptcy.
  • BXP has a Altman-Z score of 0.48. This is comparable to the rest of the industry: BXP outperforms 51.22% of its industry peers.
  • A Debt/Equity ratio of 3.30 is on the high side and indicates that BXP has dependencies on debt financing.
  • The Debt to Equity ratio of BXP (3.30) is worse than 78.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.3
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0.53
WACC6.04%
BXP Yearly LT Debt VS Equity VS FCFBXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

2.3 Liquidity

  • BXP has a Current Ratio of 1.73. This is a normal value and indicates that BXP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BXP (1.73) is better than 84.55% of its industry peers.
  • BXP has a Quick Ratio of 1.73. This is a normal value and indicates that BXP is financially healthy and should not expect problems in meeting its short term obligations.
  • BXP's Quick ratio of 1.73 is amongst the best of the industry. BXP outperforms 84.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.73
BXP Yearly Current Assets VS Current LiabilitesBXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

3

3. BXP Growth Analysis

3.1 Past

  • The earnings per share for BXP have decreased by -8.00% in the last year.
  • BXP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.87% yearly.
  • The Revenue has been growing slightly by 2.19% in the past year.
  • BXP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.72% yearly.
EPS 1Y (TTM)-8%
EPS 3Y-27.36%
EPS 5Y-18.87%
EPS Q2Q%122.86%
Revenue 1Y (TTM)2.19%
Revenue growth 3Y3.86%
Revenue growth 5Y4.72%
Sales Q2Q%2.16%

3.2 Future

  • Based on estimates for the next years, BXP will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.19% on average per year.
  • The Revenue is expected to grow by 2.27% on average over the next years.
EPS Next Y-8.43%
EPS Next 2Y0.82%
EPS Next 3Y3.05%
EPS Next 5Y10.19%
Revenue Next Year0.63%
Revenue Next 2Y1.78%
Revenue Next 3Y2.1%
Revenue Next 5Y2.27%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BXP Yearly Revenue VS EstimatesBXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
BXP Yearly EPS VS EstimatesBXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

3

4. BXP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 26.87, which means the current valuation is very expensive for BXP.
  • BXP's Price/Earnings ratio is a bit cheaper when compared to the industry. BXP is cheaper than 72.36% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.33, BXP is valued at the same level.
  • BXP is valuated quite expensively with a Price/Forward Earnings ratio of 29.35.
  • Based on the Price/Forward Earnings ratio, BXP is valued cheaply inside the industry as 82.11% of the companies are valued more expensively.
  • BXP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.16.
Industry RankSector Rank
PE 26.87
Fwd PE 29.35
BXP Price Earnings VS Forward Price EarningsBXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BXP indicates a somewhat cheap valuation: BXP is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.18
BXP Per share dataBXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.82%
EPS Next 3Y3.05%

5

5. BXP Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.34%, BXP is a good candidate for dividend investing.
  • BXP's Dividend Yield is comparable with the industry average which is at 7.71.
  • Compared to an average S&P500 Dividend Yield of 1.82, BXP pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.34%

5.2 History

  • The dividend of BXP has a limited annual growth rate of 0.37%.
  • BXP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.37%
Div Incr Years0
Div Non Decr Years0
BXP Yearly Dividends per shareBXP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 232.34% of the earnings are spent on dividend by BXP. This is not a sustainable payout ratio.
  • The dividend of BXP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP232.34%
EPS Next 2Y0.82%
EPS Next 3Y3.05%
BXP Yearly Income VS Free CF VS DividendBXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M
BXP Dividend Payout.BXP Dividend Payout, showing the Payout Ratio.BXP Dividend Payout.PayoutRetained Earnings

BXP Fundamentals: All Metrics, Ratios and Statistics

BXP INC

NYSE:BXP (4/15/2026, 12:18:58 PM)

55.63

+0.6 (+1.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)01-27
Earnings (Next)04-28
Inst Owners117.03%
Inst Owner Change-0.01%
Ins Owners0.18%
Ins Owner Change-2.01%
Market Cap8.82B
Revenue(TTM)3.48B
Net Income(TTM)276.79M
Analysts73.08
Price Target71.23 (28.04%)
Short Float %7.97%
Short Ratio4.44
Dividend
Industry RankSector Rank
Dividend Yield 5.34%
Yearly Dividend4.06
Dividend Growth(5Y)0.37%
DP232.34%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.18%
Min EPS beat(2)-177.33%
Max EPS beat(2)170.97%
EPS beat(4)3
Avg EPS beat(4)1.48%
Min EPS beat(4)-177.33%
Max EPS beat(4)170.97%
EPS beat(8)6
Avg EPS beat(8)6.45%
EPS beat(12)8
Avg EPS beat(12)6.38%
EPS beat(16)12
Avg EPS beat(16)25.72%
Revenue beat(2)2
Avg Revenue beat(2)0.66%
Min Revenue beat(2)0.43%
Max Revenue beat(2)0.89%
Revenue beat(4)4
Avg Revenue beat(4)0.89%
Min Revenue beat(4)0.23%
Max Revenue beat(4)2.02%
Revenue beat(8)8
Avg Revenue beat(8)1.44%
Revenue beat(12)12
Avg Revenue beat(12)1.41%
Revenue beat(16)16
Avg Revenue beat(16)1.53%
PT rev (1m)-7.37%
PT rev (3m)-11.19%
EPS NQ rev (1m)-6.94%
EPS NQ rev (3m)-21.48%
EPS NY rev (1m)-6.94%
EPS NY rev (3m)-16.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.64%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 26.87
Fwd PE 29.35
P/S 2.53
P/FCF N/A
P/OCF 7.09
P/B 1.71
P/tB 1.71
EV/EBITDA 12.18
EPS(TTM)2.07
EY3.72%
EPS(NY)1.9
Fwd EY3.41%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)7.85
OCFY14.11%
SpS21.95
BVpS32.45
TBVpS32.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number38.8749 (-30.12%)
Profitability
Industry RankSector Rank
ROA 1.06%
ROE 5.38%
ROCE 4.17%
ROIC 3.2%
ROICexc 3.4%
ROICexgc 3.4%
OM 29.13%
PM (TTM) 7.95%
GM 60.17%
FCFM N/A
ROA(3y)0.61%
ROA(5y)1.51%
ROE(3y)2.96%
ROE(5y)6.24%
ROIC(3y)3.24%
ROIC(5y)3.38%
ROICexc(3y)3.44%
ROICexc(5y)3.53%
ROICexgc(3y)3.44%
ROICexgc(5y)3.53%
ROCE(3y)4.17%
ROCE(5y)4.32%
ROICexgc growth 3Y-2.84%
ROICexgc growth 5Y-0.67%
ROICexc growth 3Y-2.84%
ROICexc growth 5Y-0.67%
OM growth 3Y-5.16%
OM growth 5Y-2.34%
PM growth 3Y-33.71%
PM growth 5Y-23.91%
GM growth 3Y-1.51%
GM growth 5Y-0.7%
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 3.3
Debt/FCF N/A
Debt/EBITDA 8.81
Cap/Depr 141.99%
Cap/Sales 37.19%
Interest Coverage 1.5
Cash Conversion 64.64%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.73
Altman-Z 0.48
F-Score6
WACC6.04%
ROIC/WACC0.53
Cap/Depr(3y)130.95%
Cap/Depr(5y)169.78%
Cap/Sales(3y)33.9%
Cap/Sales(5y)42.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8%
EPS 3Y-27.36%
EPS 5Y-18.87%
EPS Q2Q%122.86%
EPS Next Y-8.43%
EPS Next 2Y0.82%
EPS Next 3Y3.05%
EPS Next 5Y10.19%
Revenue 1Y (TTM)2.19%
Revenue growth 3Y3.86%
Revenue growth 5Y4.72%
Sales Q2Q%2.16%
Revenue Next Year0.63%
Revenue Next 2Y1.78%
Revenue Next 3Y2.1%
Revenue Next 5Y2.27%
EBIT growth 1Y-0.74%
EBIT growth 3Y-1.5%
EBIT growth 5Y2.27%
EBIT Next Year93.41%
EBIT Next 3Y27.18%
EBIT Next 5Y16.85%
FCF growth 1Y-150.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.86%
OCF growth 3Y-0.98%
OCF growth 5Y1.48%

BXP INC / BXP Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BXP INC?

ChartMill assigns a fundamental rating of 3 / 10 to BXP.


What is the valuation status of BXP INC (BXP) stock?

ChartMill assigns a valuation rating of 3 / 10 to BXP INC (BXP). This can be considered as Overvalued.


How profitable is BXP INC (BXP) stock?

BXP INC (BXP) has a profitability rating of 4 / 10.


What is the financial health of BXP INC (BXP) stock?

The financial health rating of BXP INC (BXP) is 3 / 10.


Is the dividend of BXP INC sustainable?

The dividend rating of BXP INC (BXP) is 5 / 10 and the dividend payout ratio is 232.34%.